CWC Advisors, LLC.: SIVR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CWC Advisors, LLC. on SIVR, newest first. How the timeline and the estimate are built.
CWC Advisors, LLC. held 8,727 SIVR shares at 2026-06-30 per its 13F-HR filed 2026-07-21.
the latest 13F is the newest step
- period ended2026-06-3013F 8,727 sharesChange vs previous 13F 0 shares
0.22% of the 13F portfolio, value $490,632.
13F-HR 0001941040-26-000433 filed by CWC Advisors, LLC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 8,727 sharesChange vs previous 13F +271 shares
0.3% of the 13F portfolio, value $624,940.
13F-HR 0001941040-26-000223 filed by CWC Advisors, LLC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 8,456 sharesChange vs previous 13F -562 shares
0.28% of the 13F portfolio, value $571,964.
13F-HR 0001941040-26-000043 filed by CWC Advisors, LLC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 9,018 sharesChange vs previous 13F -1,865 shares
0.2% of the 13F portfolio, value $401,121.
13F-HR 0001941040-25-000544 filed by CWC Advisors, LLC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 10,883 sharesChange vs previous 13F +1,000 shares
0.19% of the 13F portfolio, value $374,484.
13F-HR 0001941040-25-000345 filed by CWC Advisors, LLC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 9,883 sharesChange vs previous 13F not available
0.18% of the 13F portfolio, value $321,296.
13F-HR 0001941040-25-000232 filed by CWC Advisors, LLC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).